Patient with Myeloma Who Develops Thrombotic Microangiopathy without Hemolysis

CONCLUSION:This case highlights the importance of a pathologic evaluation of affected tissue when initial work up is insufficient. This case also poses a question of the need for further evaluation of TMAs, given the lack of hemolysis in our patient. Further research is needed to evaluate the relationship between myeloma therapy as the cause of TMA.DisclosuresNo relevant conflicts of interest to declare.

Source: Blood - November 21, 2018 Category: Hematology Authors: Alvarez Argote, J. Tags: 653. Myeloma: Therapy, excluding Transplantation Source Type: research